United States POCT Rapid Diagnostic Reagent Market was valued at USD 4.3 Billion in 2022 and is projected to reach USD 6.9 Billion by 2030, growing at a CAGR of 7.5% from 2024 to 2030.
The US POCT Rapid Diagnostic Reagent Market is rapidly evolving, driven by the demand for quick, accurate, and efficient diagnostic tools across various industries. Point-of-care testing (POCT) has gained significant traction due to its ability to provide near-instant results without requiring specialized laboratory settings. This development has revolutionized the healthcare landscape, as it allows for faster decision-making in critical situations.
The market for POCT rapid diagnostic reagents in the United States is witnessing exponential growth, fueled by the increasing need for timely diagnostics in medical emergencies, routine health screenings, and disease monitoring. POCT reagents are used for various testing types, including glucose monitoring, infectious disease detection, cardiac biomarkers, and more. These reagents offer numerous benefits, such as reduced wait times for results, enhanced patient satisfaction, and the ability to conduct testing in diverse settings like home care, clinics, and emergency departments.
Industries driving this demand range from healthcare facilities and laboratories to research institutions and pharmaceutical companies. The healthcare sector is the primary adopter of POCT, with hospitals, urgent care centers, and even pharmacies seeking to improve the speed of diagnoses and patient outcomes. The ongoing trend of at-home testing, particularly in light of the COVID-19 pandemic, has significantly boosted the demand for these reagents.
Furthermore, advancements in technology are also contributing to the expansion of the market. With innovations such as microfluidic devices and wearable testing kits, POCT reagents are becoming more accessible and user-friendly, making them ideal for a wide array of applications. As a result, industries are increasingly relying on POCT for accurate and real-time data to improve patient care and streamline diagnostic procedures.
The US POCT Rapid Diagnostic Reagent Market continues to witness innovations, regulatory advancements, and an increasing shift towards preventive healthcare. This dynamic environment promises further growth, providing more opportunities for manufacturers, healthcare providers, and other stakeholders to leverage these advanced diagnostic tools.
Get an In-Depth Research Analysis of the US POCT Rapid Diagnostic Reagent Market Size And Forecast [2025-2032]
Hologic Inc.
Thermo Fisher Scientific
Inc.
F. Hoffman-La Roche Ltd.
Perkin Elmer
Inc.
Veredus Laboratories
ADT Biotech Sdn Bhd
Zhejiang Orient Gene Biotech Co.
Ltd.
bioMérieux SA
Danaher
Mylab Discovery Solutions Pvt. Ltd.
Neuberg Diagnostics
ALDATU BIOSCIENCES
Quidel Corporation
Quest Diagnostics
Luminex Corporation
Abbott
Guangzhou Wondfo Biotech Co.
Ltd.
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US POCT Rapid Diagnostic Reagent Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US POCT Rapid Diagnostic Reagent Market
Immunoassay-based POCT Diagnostics
Microfluidics-based POCT Diagnostics
Polymerase Chain Reaction (PCR)-based POCT Diagnostics
Dipsticks & Lateral Flow Tests
Other POCT Diagnostics
Infectious Disease Testing
Cardiac Markers Testing
Diabetes Testing
Pregnancy and Fertility Testing
Others
Hospitals
Diagnostic Laboratories
Home Care Settings
Ambulatory Surgical Centers
Other Healthcare Providers
Immunoassay Technology
Microfluidics Technology
Optical Technology
Electrochemical Technology
Others
Blood Samples
Urine Samples
Saliva Samples
Other Samples
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ POCT Rapid Diagnostic Reagent Market Research Analysis
1. Introduction of the US POCT Rapid Diagnostic Reagent Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US POCT Rapid Diagnostic Reagent Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US POCT Rapid Diagnostic Reagent Market, By Type
6. US POCT Rapid Diagnostic Reagent Market, By Application
7. US POCT Rapid Diagnostic Reagent Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US POCT Rapid Diagnostic Reagent Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/